Barclays’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,952
Closed -$24K 5020
2022
Q1
$24K Sell
7,952
-51,495
-87% -$155K ﹤0.01% 4285
2021
Q4
$267K Buy
59,447
+39,919
+204% +$179K ﹤0.01% 2744
2021
Q3
$94K Buy
19,528
+13,272
+212% +$63.9K ﹤0.01% 3240
2021
Q2
$42K Sell
6,256
-62,654
-91% -$421K ﹤0.01% 3467
2021
Q1
$486K Buy
68,910
+22,450
+48% +$158K ﹤0.01% 2669
2020
Q4
$291K Sell
46,460
-5,558
-11% -$34.8K ﹤0.01% 2551
2020
Q3
$281K Sell
52,018
-2,528
-5% -$13.7K ﹤0.01% 2575
2020
Q2
$285K Buy
54,546
+43,515
+394% +$227K ﹤0.01% 2629
2020
Q1
$34K Sell
11,031
-21,968
-67% -$67.7K ﹤0.01% 3243
2019
Q4
$133K Buy
32,999
+16,543
+101% +$66.7K ﹤0.01% 3353
2019
Q3
$71K Sell
16,456
-4,886
-23% -$21.1K ﹤0.01% 3567
2019
Q2
$85K Buy
21,342
+11,906
+126% +$47.4K ﹤0.01% 3667
2019
Q1
$51K Buy
9,436
+6,935
+277% +$37.5K ﹤0.01% 3640
2018
Q4
$13K Sell
2,501
-9,474
-79% -$49.2K ﹤0.01% 3489
2018
Q3
$117K Buy
11,975
+9,611
+407% +$93.9K ﹤0.01% 3329
2018
Q2
$24K Sell
2,364
-3,543
-60% -$36K ﹤0.01% 3561
2018
Q1
$77K Sell
5,907
-12,698
-68% -$166K ﹤0.01% 3296
2017
Q4
$333K Buy
18,605
+52
+0.3% +$931 ﹤0.01% 2353
2017
Q3
$466K Buy
18,553
+3,155
+20% +$79.2K ﹤0.01% 1957
2017
Q2
$370K Sell
15,398
-1,648
-10% -$39.6K ﹤0.01% 2085
2017
Q1
$328K Buy
17,046
+6,936
+69% +$133K ﹤0.01% 2208
2016
Q4
$155K Sell
10,110
-14,414
-59% -$221K ﹤0.01% 2418
2016
Q3
$319K Buy
24,524
+19,090
+351% +$248K ﹤0.01% 1930
2016
Q2
$76K Buy
+5,434
New +$76K ﹤0.01% 2446
2015
Q4
Sell
-64
Closed -$1K 3870
2015
Q3
$1K Sell
64
-169
-73% -$2.64K ﹤0.01% 3790
2015
Q2
$6K Buy
+233
New +$6K ﹤0.01% 3544
2013
Q3
Sell
-986
Closed -$36K 4329
2013
Q2
$36K Buy
+986
New +$36K ﹤0.01% 3481